UiPath CEO Daniel Dines Sells 1.4 Million Shares for $22.5 Million
Key Points
The transaction involved the sale of ~1.4 million shares at $16.07 per share for a total value of ~$22.5 million.
The disposition reduced the direct equity holdings of the insider by 5% as of August 19, 2026.
The entire transaction was conducted through direct ownership, with no indirect holdings reported in the filing.
Execution followed a pre-arranged Rule 10b5-1 trading plan, providing a systematic approach to portfolio liquidity.
- 10 stocks we like better than UiPath ›
Daniel Dines, CEO and Chairman, reported a sale of ~1.4 million shares of UiPath, Inc.(NYSE:PATH) on Aug. 19, 2026. SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $22.5 million |
| Shares sold | ~1.4 million |
| Post-transaction shares (directly held) | ~26.5 million |
| Post-transaction value | $418.03 million |
Transaction value based on SEC Form 4 weighted average sale price ($16.07); post-transaction value based on Aug. 19, 2026, market close ($15.78).
Key questions
- How does the execution price compare to recent market levels?
The shares were sold at $16.07 per share, while the stock was priced at $15.58 as of the Aug. 18, 2026, market close. - What has been the performance of the stock over the past year?
UiPath shares returned 44% during the 12 months ending on the transaction date of Aug. 19, 2026. - What portion of the firm does the insider still control?
Following this sale, Daniel Dines maintains a 5% ownership stake in the company, directly holding ~26.5 million shares. - What was the mechanism for this transaction?
The sale was executed under a Rule 10b5-1 plan, which allows insiders to establish a pre-determined schedule for trading shares to avoid potential conflicts involving material non-public information.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-18) | $15.58 |
| Market Capitalization | $8.1 billion |
| Revenue (TTM) | $1.7 billion |
| Net Income (TTM) | $282.3 million |
Company Snapshot
- UiPath delivers a comprehensive Robotic Process Automation (RPA) ecosystem that enables organizations to design, deploy, execute, and manage enterprise automation initiatives across their operations.
- The company generates revenue through its integrated software platform that combines artificial intelligence capabilities with advanced features such as desktop activity recording and process analytics, serving as the foundational technology for digital transformation initiatives.
- UiPath primarily serves enterprise organizations across the United States, Romania, and Japan that seek to automate repetitive business processes and improve operational efficiency through intelligent automation solutions.
UiPath is a leading provider of enterprise automation software with a market capitalization of $8.1 billion and TTM revenue of $1.7 billion, demonstrating strong profitability with TTM net income of $282.3 million. The company's competitive advantage stems from its integrated platform, which seamlessly combines RPA, artificial intelligence, and advanced analytics, enabling organizations to achieve significant operational improvements. With a 43.59% one-year stock price appreciation, UiPath has established itself as a critical infrastructure provider in the enterprise automation market.
What this transaction means for investors
Dines's sale of UiPath stock likely means little for investors. He conducted the transaction under the Rule 10b5-1 framework, meaning he pre-planned it. Moreover, it accounted for just 5% of his holdings, which suggests the sale was a portfolio management decision that bears little relation to his views on the stock's future.
In fact, the state of the tech stock probably justifies his decision to keep the other 95% of his shares. Although the stock is up over the last year, it trades at levels well below its 2021 bull market peak.
Today, UiPath is a profitable company with revenue growing at double-digit rates year over year. Moreover, while it might have traded at nosebleed valuations five years ago, today, it trades at just 26 times earnings, slightly below the S&P 500 average P/E ratio of 30.
Amid these conditions, UiPath looks more like a buy than a sell, making any massive insider sales less likely.
Should you buy stock in UiPath right now?
Before you buy stock in UiPath, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UiPath wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $432,621!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,335,314!*
Now, it’s worth noting Stock Advisor’s total average return is 976% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 20, 2026.
Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends UiPath. The Motley Fool has a disclosure policy.
Recommended Articles
